Cargando…
Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK)
SGC-GAK-1 (1) is a potent, selective, cell-active chemical probe for cyclin G-associated kinase (GAK). However, 1 was rapidly metabolized in mouse liver microsomes by cytochrome P450-mediated oxidation, displaying rapid clearance in liver microsomes and in mice, which limited its utility in in vivo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891286/ https://www.ncbi.nlm.nih.gov/pubmed/31698822 http://dx.doi.org/10.3390/molecules24224016 |
_version_ | 1783475777777434624 |
---|---|
author | Asquith, Christopher R. M. Bennett, James M. Su, Lianyong Laitinen, Tuomo Elkins, Jonathan M. Pickett, Julie E. Wells, Carrow I. Li, Zengbiao Willson, Timothy M. Zuercher, William J. |
author_facet | Asquith, Christopher R. M. Bennett, James M. Su, Lianyong Laitinen, Tuomo Elkins, Jonathan M. Pickett, Julie E. Wells, Carrow I. Li, Zengbiao Willson, Timothy M. Zuercher, William J. |
author_sort | Asquith, Christopher R. M. |
collection | PubMed |
description | SGC-GAK-1 (1) is a potent, selective, cell-active chemical probe for cyclin G-associated kinase (GAK). However, 1 was rapidly metabolized in mouse liver microsomes by cytochrome P450-mediated oxidation, displaying rapid clearance in liver microsomes and in mice, which limited its utility in in vivo studies. Chemical modifications of 1 that improved metabolic stability, generally resulted in decreased GAK potency. The best analog in terms of GAK activity in cells was 6-bromo-N-(1H-indazol-6-yl)quinolin-4-amine (35) (IC(50) = 1.4 μM), showing improved stability in liver microsomes while still maintaining a narrow spectrum activity across the kinome. As an alternative to scaffold modifications we also explored the use of the broad-spectrum cytochrome P450 inhibitor 1-aminobenzotriazole (ABT) to decrease intrinsic clearance of aminoquinoline GAK inhibitors. Taken together, these approaches point towards the development of an in vivo chemical probe for the dark kinase GAK. |
format | Online Article Text |
id | pubmed-6891286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68912862019-12-12 Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) Asquith, Christopher R. M. Bennett, James M. Su, Lianyong Laitinen, Tuomo Elkins, Jonathan M. Pickett, Julie E. Wells, Carrow I. Li, Zengbiao Willson, Timothy M. Zuercher, William J. Molecules Article SGC-GAK-1 (1) is a potent, selective, cell-active chemical probe for cyclin G-associated kinase (GAK). However, 1 was rapidly metabolized in mouse liver microsomes by cytochrome P450-mediated oxidation, displaying rapid clearance in liver microsomes and in mice, which limited its utility in in vivo studies. Chemical modifications of 1 that improved metabolic stability, generally resulted in decreased GAK potency. The best analog in terms of GAK activity in cells was 6-bromo-N-(1H-indazol-6-yl)quinolin-4-amine (35) (IC(50) = 1.4 μM), showing improved stability in liver microsomes while still maintaining a narrow spectrum activity across the kinome. As an alternative to scaffold modifications we also explored the use of the broad-spectrum cytochrome P450 inhibitor 1-aminobenzotriazole (ABT) to decrease intrinsic clearance of aminoquinoline GAK inhibitors. Taken together, these approaches point towards the development of an in vivo chemical probe for the dark kinase GAK. MDPI 2019-11-06 /pmc/articles/PMC6891286/ /pubmed/31698822 http://dx.doi.org/10.3390/molecules24224016 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Asquith, Christopher R. M. Bennett, James M. Su, Lianyong Laitinen, Tuomo Elkins, Jonathan M. Pickett, Julie E. Wells, Carrow I. Li, Zengbiao Willson, Timothy M. Zuercher, William J. Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title | Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title_full | Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title_fullStr | Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title_full_unstemmed | Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title_short | Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK) |
title_sort | towards the development of an in vivo chemical probe for cyclin g associated kinase (gak) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891286/ https://www.ncbi.nlm.nih.gov/pubmed/31698822 http://dx.doi.org/10.3390/molecules24224016 |
work_keys_str_mv | AT asquithchristopherrm towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT bennettjamesm towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT sulianyong towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT laitinentuomo towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT elkinsjonathanm towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT pickettjuliee towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT wellscarrowi towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT lizengbiao towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT willsontimothym towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak AT zuercherwilliamj towardsthedevelopmentofaninvivochemicalprobeforcyclingassociatedkinasegak |